Emerging infectious diseases can be defined as outbreaks of previously unknown or unidentified diseases, previously known diseases that are rapidly increasing in incidence or geographic range in the last 24 years, and persistence and circulation of infectious diseases that can't be controlled. Emerging infectious diseases have been caused by pathogens including but not limited to SARS, MERS, SARS-CoV-2, Caliciviruses, Borrelia burgdorferi, hantavirus, dengue virus, chikungunya virus, West Nile virus, and the Zika virus. Re-emerging diseases reappear after they have been on a significant decline. Human behavior and environmental factors may affect reemergence. Re-emerging diseases include malaria, pneumococcal disease, diarrheal disease by viruses, cholera, pertussis, influenza, and gonorrhea.
Both emerging and re-emerging infectious diseases are caused by viruses, bacteria, and parasites. Early and accurate identification and surveillance are the two most important factors for controlling pandemic or endemic caused by infectious pathogens. Without epidemiological study and genomic information of pathogens, it is difficult to measure and track the source of infection, characterize the transmission route of pathogens in hosts, and predict and evaluate the risks of larger outbreaks of these pathogens. The emergence of the ongoing COVID-19 pandemic by SARS-CoV-2 provides valuable insights in this respect.
This Research Topic aims to create a platform for scientists and researchers to analyze and explore the etiology and epidemiology of emerging and re-emerging infectious diseases and determine genomic characteristics and evolution of pathogens.
This Research Topic will produce a broad scope on the epidemiology and symptoms characterization, and diagnosis of emerging and re-emerging infectious diseases and genomic evolution, and phylogenetic analysis of pathogens, including but not limited to both dry lab (computational bioinformatics) and wet lab (in vivo/in vitro) studies on: epidemiology of the disease, recombination, re-assortment, and mutational analysis, phylogenetic tree building, evolutionary rate estimation, molecular epidemiology and so on.
Rapid identification and evaluation of detection methods of pathogens based on molecular and immunological approaches should also be included. This Research Topic will welcome Original Research, Reviews, Mini Reviews, Case Reports, and Systematic Reviews focusing these themes on the following pathogens involved in emerging and reemerging diseases:
• Diarrheal viruses (Reoviridae, Caliciviridae, etc.)
• Filovirus (Ebola, Marburg, etc.)
• Hemorrhagic fever viruses (Lassa fever, Crimean–Congo hemorrhagic fever, etc.),
• Coronavirus (SARS, MERS, SARS-CoV-2 etc.)
• Nipah virus
• West Nile virus
• Influenza virus
• Dengue virus
• Zika virus
• Chikungunya virus
• Vibrio cholerae
Emerging infectious diseases can be defined as outbreaks of previously unknown or unidentified diseases, previously known diseases that are rapidly increasing in incidence or geographic range in the last 24 years, and persistence and circulation of infectious diseases that can't be controlled. Emerging infectious diseases have been caused by pathogens including but not limited to SARS, MERS, SARS-CoV-2, Caliciviruses, Borrelia burgdorferi, hantavirus, dengue virus, chikungunya virus, West Nile virus, and the Zika virus. Re-emerging diseases reappear after they have been on a significant decline. Human behavior and environmental factors may affect reemergence. Re-emerging diseases include malaria, pneumococcal disease, diarrheal disease by viruses, cholera, pertussis, influenza, and gonorrhea.
Both emerging and re-emerging infectious diseases are caused by viruses, bacteria, and parasites. Early and accurate identification and surveillance are the two most important factors for controlling pandemic or endemic caused by infectious pathogens. Without epidemiological study and genomic information of pathogens, it is difficult to measure and track the source of infection, characterize the transmission route of pathogens in hosts, and predict and evaluate the risks of larger outbreaks of these pathogens. The emergence of the ongoing COVID-19 pandemic by SARS-CoV-2 provides valuable insights in this respect.
This Research Topic aims to create a platform for scientists and researchers to analyze and explore the etiology and epidemiology of emerging and re-emerging infectious diseases and determine genomic characteristics and evolution of pathogens.
This Research Topic will produce a broad scope on the epidemiology and symptoms characterization, and diagnosis of emerging and re-emerging infectious diseases and genomic evolution, and phylogenetic analysis of pathogens, including but not limited to both dry lab (computational bioinformatics) and wet lab (in vivo/in vitro) studies on: epidemiology of the disease, recombination, re-assortment, and mutational analysis, phylogenetic tree building, evolutionary rate estimation, molecular epidemiology and so on.
Rapid identification and evaluation of detection methods of pathogens based on molecular and immunological approaches should also be included. This Research Topic will welcome Original Research, Reviews, Mini Reviews, Case Reports, and Systematic Reviews focusing these themes on the following pathogens involved in emerging and reemerging diseases:
• Diarrheal viruses (Reoviridae, Caliciviridae, etc.)
• Filovirus (Ebola, Marburg, etc.)
• Hemorrhagic fever viruses (Lassa fever, Crimean–Congo hemorrhagic fever, etc.),
• Coronavirus (SARS, MERS, SARS-CoV-2 etc.)
• Nipah virus
• West Nile virus
• Influenza virus
• Dengue virus
• Zika virus
• Chikungunya virus
• Vibrio cholerae
